PDB Short entry for 5GSA HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-AUG-16 5GSA TITLE EED IN COMPLEX WITH AN ALLOSTERIC PRC2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYCOMB PROTEIN EED; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 76-441; COMPND 5 SYNONYM: HEED,WD PROTEIN ASSOCIATING WITH INTEGRIN CYTOPLASMIC TAILS COMPND 6 1,WAIT-1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HISTONE-LYSINE N-METHYLTRANSFERASE EZH2; COMPND 10 CHAIN: C, D; COMPND 11 SYNONYM: ENX-1,ENHANCER OF ZESTE HOMOLOG 2,LYSINE N-METHYLTRANSFERASE COMPND 12 6; COMPND 13 EC: 2.1.1.43; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EED; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS EED, PRC2, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.ZHAO,M.ZHAO,X.LUO,H.ZHANG REVDAT 3 08-NOV-23 5GSA 1 REMARK REVDAT 2 05-APR-17 5GSA 1 JRNL REVDAT 1 01-FEB-17 5GSA 0 JRNL AUTH W.QI,K.ZHAO,J.GU,Y.HUANG,Y.WANG,H.ZHANG,M.ZHANG,J.ZHANG, JRNL AUTH 2 Z.YU,L.LI,L.TENG,S.CHUAI,C.ZHANG,M.ZHAO,H.CHAN,Z.CHEN, JRNL AUTH 3 D.FANG,Q.FEI,L.FENG,L.FENG,Y.GAO,H.GE,X.GE,G.LI,A.LINGEL, JRNL AUTH 4 Y.LIN,Y.LIU,F.LUO,M.SHI,L.WANG,Z.WANG,Y.YU,J.ZENG,C.ZENG, JRNL AUTH 5 L.ZHANG,Q.ZHANG,S.ZHOU,C.OYANG,P.ATADJA,E.LI JRNL TITL AN ALLOSTERIC PRC2 INHIBITOR TARGETING THE H3K27ME3 BINDING JRNL TITL 2 POCKET OF JRNL REF NAT. CHEM. BIOL. V. 13 381 2017 JRNL REFN ESSN 1552-4469 JRNL PMID 28135235 JRNL DOI 10.1038/NCHEMBIO.2304 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 30258 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1531 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.58 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.19 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2812 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2196 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2673 REMARK 3 BIN R VALUE (WORKING SET) : 0.2157 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.94 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 139 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6354 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -20.88790 REMARK 3 B22 (A**2) : 11.02300 REMARK 3 B33 (A**2) : 9.86490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.286 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.659 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.296 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.586 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.296 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.871 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6569 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8892 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2304 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 170 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 941 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6569 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 831 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7543 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.17 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.31 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.47 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5GSA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1300001349. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97930 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 130 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30316 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.53500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2QXV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, 16% PEG 8000, PH 8.0, REMARK 280 EVAPORATION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 46.89650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 88.95400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 46.89650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 88.95400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 75 REMARK 465 LYS A 76 REMARK 465 LYS A 77 REMARK 465 ASN A 283 REMARK 465 LYS A 284 REMARK 465 THR A 285 REMARK 465 ASN A 286 REMARK 465 ARG A 441 REMARK 465 GLY B 75 REMARK 465 LYS B 76 REMARK 465 LYS B 77 REMARK 465 ARG B 441 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 79 -9.53 71.72 REMARK 500 ASN A 93 9.90 58.17 REMARK 500 SER A 118 -131.75 56.25 REMARK 500 HIS A 213 0.42 87.13 REMARK 500 PHE A 299 143.79 -176.64 REMARK 500 SER A 323 -150.88 -130.15 REMARK 500 GLU A 325 12.21 -62.40 REMARK 500 GLU A 347 116.52 -36.91 REMARK 500 CYS A 361 57.03 -150.64 REMARK 500 TYR A 365 59.28 73.16 REMARK 500 PRO A 396 1.09 -69.33 REMARK 500 LYS B 79 -61.62 -97.53 REMARK 500 TYR B 80 132.02 -35.56 REMARK 500 SER B 118 -133.75 46.48 REMARK 500 LEU B 135 -72.83 -96.33 REMARK 500 SER B 159 17.43 59.27 REMARK 500 HIS B 213 -3.92 86.54 REMARK 500 PHE B 299 145.95 -171.66 REMARK 500 SER B 323 -144.93 -119.55 REMARK 500 TYR B 365 58.57 78.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 73K A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 73K B 501 DBREF 5GSA A 76 441 UNP O75530 EED_HUMAN 76 441 DBREF 5GSA B 76 441 UNP O75530 EED_HUMAN 76 441 DBREF 5GSA C 40 68 UNP Q15910 EZH2_HUMAN 40 68 DBREF 5GSA D 40 68 UNP Q15910 EZH2_HUMAN 40 68 SEQADV 5GSA GLY A 75 UNP O75530 EXPRESSION TAG SEQADV 5GSA GLY B 75 UNP O75530 EXPRESSION TAG SEQRES 1 A 367 GLY LYS LYS CYS LYS TYR SER PHE LYS CYS VAL ASN SER SEQRES 2 A 367 LEU LYS GLU ASP HIS ASN GLN PRO LEU PHE GLY VAL GLN SEQRES 3 A 367 PHE ASN TRP HIS SER LYS GLU GLY ASP PRO LEU VAL PHE SEQRES 4 A 367 ALA THR VAL GLY SER ASN ARG VAL THR LEU TYR GLU CYS SEQRES 5 A 367 HIS SER GLN GLY GLU ILE ARG LEU LEU GLN SER TYR VAL SEQRES 6 A 367 ASP ALA ASP ALA ASP GLU ASN PHE TYR THR CYS ALA TRP SEQRES 7 A 367 THR TYR ASP SER ASN THR SER HIS PRO LEU LEU ALA VAL SEQRES 8 A 367 ALA GLY SER ARG GLY ILE ILE ARG ILE ILE ASN PRO ILE SEQRES 9 A 367 THR MET GLN CYS ILE LYS HIS TYR VAL GLY HIS GLY ASN SEQRES 10 A 367 ALA ILE ASN GLU LEU LYS PHE HIS PRO ARG ASP PRO ASN SEQRES 11 A 367 LEU LEU LEU SER VAL SER LYS ASP HIS ALA LEU ARG LEU SEQRES 12 A 367 TRP ASN ILE GLN THR ASP THR LEU VAL ALA ILE PHE GLY SEQRES 13 A 367 GLY VAL GLU GLY HIS ARG ASP GLU VAL LEU SER ALA ASP SEQRES 14 A 367 TYR ASP LEU LEU GLY GLU LYS ILE MET SER CYS GLY MET SEQRES 15 A 367 ASP HIS SER LEU LYS LEU TRP ARG ILE ASN SER LYS ARG SEQRES 16 A 367 MET MET ASN ALA ILE LYS GLU SER TYR ASP TYR ASN PRO SEQRES 17 A 367 ASN LYS THR ASN ARG PRO PHE ILE SER GLN LYS ILE HIS SEQRES 18 A 367 PHE PRO ASP PHE SER THR ARG ASP ILE HIS ARG ASN TYR SEQRES 19 A 367 VAL ASP CYS VAL ARG TRP LEU GLY ASP LEU ILE LEU SER SEQRES 20 A 367 LYS SER CYS GLU ASN ALA ILE VAL CYS TRP LYS PRO GLY SEQRES 21 A 367 LYS MET GLU ASP ASP ILE ASP LYS ILE LYS PRO SER GLU SEQRES 22 A 367 SER ASN VAL THR ILE LEU GLY ARG PHE ASP TYR SER GLN SEQRES 23 A 367 CYS ASP ILE TRP TYR MET ARG PHE SER MET ASP PHE TRP SEQRES 24 A 367 GLN LYS MET LEU ALA LEU GLY ASN GLN VAL GLY LYS LEU SEQRES 25 A 367 TYR VAL TRP ASP LEU GLU VAL GLU ASP PRO HIS LYS ALA SEQRES 26 A 367 LYS CYS THR THR LEU THR HIS HIS LYS CYS GLY ALA ALA SEQRES 27 A 367 ILE ARG GLN THR SER PHE SER ARG ASP SER SER ILE LEU SEQRES 28 A 367 ILE ALA VAL CYS ASP ASP ALA SER ILE TRP ARG TRP ASP SEQRES 29 A 367 ARG LEU ARG SEQRES 1 B 367 GLY LYS LYS CYS LYS TYR SER PHE LYS CYS VAL ASN SER SEQRES 2 B 367 LEU LYS GLU ASP HIS ASN GLN PRO LEU PHE GLY VAL GLN SEQRES 3 B 367 PHE ASN TRP HIS SER LYS GLU GLY ASP PRO LEU VAL PHE SEQRES 4 B 367 ALA THR VAL GLY SER ASN ARG VAL THR LEU TYR GLU CYS SEQRES 5 B 367 HIS SER GLN GLY GLU ILE ARG LEU LEU GLN SER TYR VAL SEQRES 6 B 367 ASP ALA ASP ALA ASP GLU ASN PHE TYR THR CYS ALA TRP SEQRES 7 B 367 THR TYR ASP SER ASN THR SER HIS PRO LEU LEU ALA VAL SEQRES 8 B 367 ALA GLY SER ARG GLY ILE ILE ARG ILE ILE ASN PRO ILE SEQRES 9 B 367 THR MET GLN CYS ILE LYS HIS TYR VAL GLY HIS GLY ASN SEQRES 10 B 367 ALA ILE ASN GLU LEU LYS PHE HIS PRO ARG ASP PRO ASN SEQRES 11 B 367 LEU LEU LEU SER VAL SER LYS ASP HIS ALA LEU ARG LEU SEQRES 12 B 367 TRP ASN ILE GLN THR ASP THR LEU VAL ALA ILE PHE GLY SEQRES 13 B 367 GLY VAL GLU GLY HIS ARG ASP GLU VAL LEU SER ALA ASP SEQRES 14 B 367 TYR ASP LEU LEU GLY GLU LYS ILE MET SER CYS GLY MET SEQRES 15 B 367 ASP HIS SER LEU LYS LEU TRP ARG ILE ASN SER LYS ARG SEQRES 16 B 367 MET MET ASN ALA ILE LYS GLU SER TYR ASP TYR ASN PRO SEQRES 17 B 367 ASN LYS THR ASN ARG PRO PHE ILE SER GLN LYS ILE HIS SEQRES 18 B 367 PHE PRO ASP PHE SER THR ARG ASP ILE HIS ARG ASN TYR SEQRES 19 B 367 VAL ASP CYS VAL ARG TRP LEU GLY ASP LEU ILE LEU SER SEQRES 20 B 367 LYS SER CYS GLU ASN ALA ILE VAL CYS TRP LYS PRO GLY SEQRES 21 B 367 LYS MET GLU ASP ASP ILE ASP LYS ILE LYS PRO SER GLU SEQRES 22 B 367 SER ASN VAL THR ILE LEU GLY ARG PHE ASP TYR SER GLN SEQRES 23 B 367 CYS ASP ILE TRP TYR MET ARG PHE SER MET ASP PHE TRP SEQRES 24 B 367 GLN LYS MET LEU ALA LEU GLY ASN GLN VAL GLY LYS LEU SEQRES 25 B 367 TYR VAL TRP ASP LEU GLU VAL GLU ASP PRO HIS LYS ALA SEQRES 26 B 367 LYS CYS THR THR LEU THR HIS HIS LYS CYS GLY ALA ALA SEQRES 27 B 367 ILE ARG GLN THR SER PHE SER ARG ASP SER SER ILE LEU SEQRES 28 B 367 ILE ALA VAL CYS ASP ASP ALA SER ILE TRP ARG TRP ASP SEQRES 29 B 367 ARG LEU ARG SEQRES 1 C 29 SER MET PHE SER SER ASN ARG GLN LYS ILE LEU GLU ARG SEQRES 2 C 29 THR GLU ILE LEU ASN GLN GLU TRP LYS GLN ARG ARG ILE SEQRES 3 C 29 GLN PRO VAL SEQRES 1 D 29 SER MET PHE SER SER ASN ARG GLN LYS ILE LEU GLU ARG SEQRES 2 D 29 THR GLU ILE LEU ASN GLN GLU TRP LYS GLN ARG ARG ILE SEQRES 3 D 29 GLN PRO VAL HET 73K A 501 26 HET 73K B 501 26 HETNAM 73K N-(FURAN-2-YLMETHYL)-8-(4-METHYLSULFONYLPHENYL)-[1,2, HETNAM 2 73K 4]TRIAZOLO[4,3-C]PYRIMIDIN-5-AMINE FORMUL 5 73K 2(C17 H15 N5 O3 S) FORMUL 7 HOH *180(H2 O) HELIX 1 AA1 SER A 267 TYR A 280 1 14 HELIX 2 AA2 SER B 267 TYR B 280 1 14 HELIX 3 AA3 MET C 41 ARG C 63 1 23 HELIX 4 AA4 MET D 41 GLN D 62 1 22 SHEET 1 AA1 4 PHE A 82 LYS A 89 0 SHEET 2 AA1 4 SER A 433 ARG A 439 -1 O ARG A 436 N ASN A 86 SHEET 3 AA1 4 ILE A 424 CYS A 429 -1 N ALA A 427 O TRP A 435 SHEET 4 AA1 4 ILE A 413 PHE A 418 -1 N SER A 417 O ILE A 426 SHEET 1 AA2 4 GLY A 98 PHE A 101 0 SHEET 2 AA2 4 LEU A 111 GLY A 117 -1 O ALA A 114 N GLN A 100 SHEET 3 AA2 4 ARG A 120 CYS A 126 -1 O CYS A 126 N LEU A 111 SHEET 4 AA2 4 ILE A 132 VAL A 139 -1 O ARG A 133 N GLU A 125 SHEET 1 AA3 4 PHE A 147 TYR A 154 0 SHEET 2 AA3 4 PRO A 161 GLY A 167 -1 O LEU A 162 N THR A 153 SHEET 3 AA3 4 ILE A 172 ASN A 176 -1 O ILE A 175 N LEU A 163 SHEET 4 AA3 4 GLN A 181 TYR A 186 -1 O GLN A 181 N ASN A 176 SHEET 1 AA4 5 ILE A 193 PHE A 198 0 SHEET 2 AA4 5 LEU A 205 SER A 210 -1 O LEU A 207 N LYS A 197 SHEET 3 AA4 5 LEU A 215 ASN A 219 -1 O TRP A 218 N LEU A 206 SHEET 4 AA4 5 THR A 224 PHE A 229 -1 O ALA A 227 N LEU A 217 SHEET 5 AA4 5 GLN A 292 ILE A 294 1 O ILE A 294 N ILE A 228 SHEET 1 AA5 4 VAL A 239 TYR A 244 0 SHEET 2 AA5 4 LYS A 250 GLY A 255 -1 O MET A 252 N ASP A 243 SHEET 3 AA5 4 LEU A 260 ARG A 264 -1 O LYS A 261 N SER A 253 SHEET 4 AA5 4 PHE A 299 THR A 301 -1 O PHE A 299 N LEU A 262 SHEET 1 AA6 4 CYS A 311 LEU A 315 0 SHEET 2 AA6 4 LEU A 318 LYS A 322 -1 O LEU A 318 N LEU A 315 SHEET 3 AA6 4 ALA A 327 PRO A 333 -1 O VAL A 329 N SER A 321 SHEET 4 AA6 4 VAL A 350 ASP A 357 -1 O LEU A 353 N CYS A 330 SHEET 1 AA7 4 SER A 369 MET A 370 0 SHEET 2 AA7 4 MET A 376 GLY A 380 -1 O ALA A 378 N SER A 369 SHEET 3 AA7 4 LEU A 386 ASP A 390 -1 O TYR A 387 N LEU A 379 SHEET 4 AA7 4 LYS A 400 LEU A 404 -1 O LEU A 404 N LEU A 386 SHEET 1 AA8 4 PHE B 82 LYS B 89 0 SHEET 2 AA8 4 SER B 433 ARG B 439 -1 O ARG B 436 N ASN B 86 SHEET 3 AA8 4 ILE B 424 CYS B 429 -1 N LEU B 425 O TRP B 437 SHEET 4 AA8 4 ILE B 413 PHE B 418 -1 N SER B 417 O ILE B 426 SHEET 1 AA9 4 LEU B 96 PHE B 101 0 SHEET 2 AA9 4 LEU B 111 GLY B 117 -1 O ALA B 114 N GLN B 100 SHEET 3 AA9 4 ARG B 120 CYS B 126 -1 O CYS B 126 N LEU B 111 SHEET 4 AA9 4 ILE B 132 VAL B 139 -1 O TYR B 138 N VAL B 121 SHEET 1 AB1 4 PHE B 147 TYR B 154 0 SHEET 2 AB1 4 PRO B 161 GLY B 167 -1 O ALA B 164 N ALA B 151 SHEET 3 AB1 4 ILE B 172 ASN B 176 -1 O ILE B 175 N LEU B 163 SHEET 4 AB1 4 GLN B 181 TYR B 186 -1 O LYS B 184 N ILE B 174 SHEET 1 AB2 5 ILE B 193 PHE B 198 0 SHEET 2 AB2 5 LEU B 205 SER B 210 -1 O LEU B 207 N LYS B 197 SHEET 3 AB2 5 LEU B 215 ASN B 219 -1 O TRP B 218 N LEU B 206 SHEET 4 AB2 5 THR B 224 PHE B 229 -1 O PHE B 229 N LEU B 215 SHEET 5 AB2 5 GLN B 292 ILE B 294 1 O ILE B 294 N ILE B 228 SHEET 1 AB3 4 VAL B 239 TYR B 244 0 SHEET 2 AB3 4 LYS B 250 GLY B 255 -1 O CYS B 254 N LEU B 240 SHEET 3 AB3 4 LEU B 260 ARG B 264 -1 O LYS B 261 N SER B 253 SHEET 4 AB3 4 PHE B 299 THR B 301 -1 O PHE B 299 N LEU B 262 SHEET 1 AB4 4 CYS B 311 LEU B 315 0 SHEET 2 AB4 4 LEU B 318 LYS B 322 -1 O LEU B 318 N LEU B 315 SHEET 3 AB4 4 ALA B 327 PRO B 333 -1 O TRP B 331 N ILE B 319 SHEET 4 AB4 4 VAL B 350 ASP B 357 -1 O LEU B 353 N CYS B 330 SHEET 1 AB5 3 PHE B 368 MET B 370 0 SHEET 2 AB5 3 MET B 376 GLY B 380 -1 O ALA B 378 N SER B 369 SHEET 3 AB5 3 LEU B 386 ASP B 390 -1 O TYR B 387 N LEU B 379 SSBOND 1 CYS A 78 CYS A 401 1555 1555 2.03 SSBOND 2 CYS B 78 CYS B 401 1555 1555 2.03 SITE 1 AC1 10 PHE A 97 TYR A 148 ASN A 194 LYS A 211 SITE 2 AC1 10 LEU A 240 ASP A 310 TYR A 365 ARG A 367 SITE 3 AC1 10 ARG A 414 HOH A 652 SITE 1 AC2 11 PHE B 97 TYR B 148 ASN B 194 LYS B 211 SITE 2 AC2 11 LEU B 240 ASP B 310 TYR B 365 ARG B 367 SITE 3 AC2 11 ARG B 414 HOH B 643 HOH B 656 CRYST1 93.793 177.908 50.532 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010662 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005621 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019789 0.00000